Surgery Partners, Inc. (SGRY)

Market Cap	2.91B
Revenue (ttm)	2.99B
Net Income (ttm)	-60.60M
Shares Out	126.38M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	25.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	821,147
Open	23.45
Previous Close	23.35
Day's Range	22.69 - 23.53
52-Week Range	21.36 - 36.92
Beta	2.77
Analysts	Buy
Price Target	38.71 (+68.23%)
Earnings Date	Nov 12, 2024

About SGRY

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty phy...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 1, 2015
• Employees: 13,500
• Stock Exchange: NASDAQ
• Ticker Symbol: SGRY
• Website: https://www.surgerypartners.com

Financial Performance

In 2023, Surgery Partners's revenue was $2.74 billion, an increase of 8.03% compared to the previous year's $2.54 billion. Losses were -$11.90 million, -78.21% less than in 2022.

Analyst Forecast

According to 8 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price forecast is $38.71, which is an increase of 68.23% from the latest price.

Price Target

$38.71

(68.23% upside)

Analyst Consensus: Buy